John J. Orloff - 12 Sep 2024 Form 4 Insider Report for Zenas BioPharma, Inc. (ZBIO)

Role
Director
Signature
By: /s/ Chase Jayasekera, Attorney-in-Fact
Issuer symbol
ZBIO
Transactions as of
12 Sep 2024
Net transactions value
$0
Form type
4
Filing time
16 Sep 2024, 21:05:31 UTC
Previous filing
23 Jul 2021
Next filing
12 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZBIO Stock Option (Right to Buy) Award $0 +18,500 $0.000000 18,500 12 Sep 2024 Common Stock 18,500 $17.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 100% of the underlying shares of common stock on September 12, 2025, the first anniversary of the vesting commencement date, subject to continued service.